3,983 Shares in Marsh & McLennan Companies, Inc. $MRSH Bought by Sfmg LLC

Sfmg LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,983 shares of the financial services provider’s stock, valued at approximately $739,000.

Other hedge funds have also recently bought and sold shares of the company. Numerai GP LLC increased its position in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after buying an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd increased its position in Marsh & McLennan Companies by 9.5% during the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after buying an additional 11,648 shares during the last quarter. Rockland Trust Co. increased its position in Marsh & McLennan Companies by 801.6% during the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after buying an additional 10,734 shares during the last quarter. Barclays PLC increased its position in Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after buying an additional 647,987 shares during the last quarter. Finally, Bridges Investment Management Inc. increased its position in Marsh & McLennan Companies by 4.4% during the third quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock worth $15,356,000 after buying an additional 3,177 shares during the last quarter. 87.99% of the stock is owned by institutional investors and hedge funds.

Marsh & McLennan Companies Stock Up 0.1%

MRSH stock opened at $159.73 on Friday. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. Marsh & McLennan Companies, Inc. has a 52-week low of $157.74 and a 52-week high of $235.78. The company has a 50-day moving average of $164.87 and a two-hundred day moving average of $172.02. The stock has a market capitalization of $77.17 billion, a price-to-earnings ratio of 19.97, a price-to-earnings-growth ratio of 2.33 and a beta of 0.65.

Marsh & McLennan Companies (NYSE:MRSH) last released its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company had revenue of $7.30 billion during the quarter. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.

Insider Buying and Selling at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.38% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Morgan Stanley lowered their target price on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a research report on Monday, April 6th. Raymond James Financial raised shares of Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price on the stock in a research report on Tuesday, February 17th. Wells Fargo & Company lowered their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 9th. JPMorgan Chase & Co. decreased their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a report on Thursday, April 9th. Finally, Citigroup upgraded shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target for the company in a report on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Marsh & McLennan Companies has a consensus rating of “Hold” and a consensus target price of $203.56.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.